These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 22291461)

  • 1. Prevalence of OmpK35 and OmpK36 porin expression in beta-lactamase and non-betalactamase- producing Klebsiella pneumoniae.
    Shakib P; Ghafourian S; Zolfaghary MR; Hushmandfar R; Ranjbar R; Sadeghifard N
    Biologics; 2012; 6():1-4. PubMed ID: 22291461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of OqxAB efflux pumps, OmpK35 and OmpK36 porins in extended-spectrum-β-lactamase-producing Klebsiella pneumoniae isolates from Iran.
    Taherpour A; Hashemi A
    Hippokratia; 2013 Oct; 17(4):355-8. PubMed ID: 25031516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Klebsiella pneumoniae Major Porins OmpK35 and OmpK36 Allow More Efficient Diffusion of β-Lactams than Their Escherichia coli Homologs OmpF and OmpC.
    Sugawara E; Kojima S; Nikaido H
    J Bacteriol; 2016 Dec; 198(23):3200-3208. PubMed ID: 27645385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced susceptibility to carbapenems in Klebsiella pneumoniae clinical isolates associated with plasmid-mediated beta-lactamase production and OmpK36 porin deficiency.
    Wang XD; Cai JC; Zhou HW; Zhang R; Chen GX
    J Med Microbiol; 2009 Sep; 58(Pt 9):1196-1202. PubMed ID: 19528170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of diverse β-lactamases presenting high-level resistance in association with OmpK35 and OmpK36 porins in ESBL-producing
    Ejaz H
    Saudi J Biol Sci; 2022 May; 29(5):3440-3447. PubMed ID: 35844436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Porin expression in clinical isolates of Klebsiella pneumoniae.
    Hernández-Allés S; Albertí S; Álvarez D; Doménech-Sánchez A; Martínez-Martínez L; Gil J; Tomás JM; Benedí VJ
    Microbiology (Reading); 1999 Mar; 145 ( Pt 3)():673-679. PubMed ID: 10217501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diminished Susceptibility to Cefoperazone/Sulbactam and Piperacillin/Tazobactam in
    Yang F; Zhao Q; Wang L; Wu J; Jiang L; Sheng L; Zhang L; Xue Z; Yi M
    Pol J Microbiol; 2022 Jun; 71(2):251-256. PubMed ID: 35716168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of OmpK35, OmpK36 Porins, and Production of β-Lactamases on Imipenem Susceptibility in Klebsiella pneumoniae Clinical Isolates, Cairo, Egypt.
    Wassef M; Abdelhaleim M; AbdulRahman E; Ghaith D
    Microb Drug Resist; 2015 Dec; 21(6):577-80. PubMed ID: 25945596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-Level Carbapenem Resistance among OXA-48-Producing
    Lumbreras-Iglesias P; Rodicio MR; Valledor P; Suárez-Zarracina T; Fernández J
    Antibiotics (Basel); 2021 Sep; 10(10):. PubMed ID: 34680754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of association of OmpK35 and OmpK36 alteration and bla
    Hamzaoui Z; Ocampo-Sosa A; Fernandez Martinez M; Landolsi S; Ferjani S; Maamar E; Saidani M; Slim A; Martinez-Martinez L; Boutiba-Ben Boubaker I
    Int J Antimicrob Agents; 2018 Dec; 52(6):898-905. PubMed ID: 29621592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbapenem and cefoxitin resistance of Klebsiella pneumoniae strains associated with porin OmpK36 loss and DHA-1 β-lactamase production.
    Shi W; Li K; Ji Y; Jiang Q; Wang Y; Shi M; Mi Z
    Braz J Microbiol; 2013; 44(2):435-42. PubMed ID: 24294234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global Trends in Proteome Remodeling of the Outer Membrane Modulate Antimicrobial Permeability in Klebsiella pneumoniae.
    Rocker A; Lacey JA; Belousoff MJ; Wilksch JJ; Strugnell RA; Davies MR; Lithgow T
    mBio; 2020 Apr; 11(2):. PubMed ID: 32291303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An ertapenem-resistant extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae clone carries a novel OmpK36 porin variant.
    García-Fernández A; Miriagou V; Papagiannitsis CC; Giordano A; Venditti M; Mancini C; Carattoli A
    Antimicrob Agents Chemother; 2010 Oct; 54(10):4178-84. PubMed ID: 20660683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spread of an OmpK36-modified ST15 Klebsiella pneumoniae variant during an outbreak involving multiple carbapenem-resistant Enterobacteriaceae species and clones.
    Novais A; Rodrigues C; Branquinho R; Antunes P; Grosso F; Boaventura L; Ribeiro G; Peixe L
    Eur J Clin Microbiol Infect Dis; 2012 Nov; 31(11):3057-63. PubMed ID: 22706513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended-Spectrum Beta-Lactamases Producing Escherichia coli and Klebsiella pneumoniae: A Multi-Centric Study Across Karnataka.
    Rao SP; Rama PS; Gurushanthappa V; Manipura R; Srinivasan K
    J Lab Physicians; 2014 Jan; 6(1):7-13. PubMed ID: 24696553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High ceftazidime hydrolysis activity and porin OmpK35 deficiency contribute to the decreased susceptibility to ceftazidime/avibactam in KPC-producing Klebsiella pneumoniae.
    Shen Z; Ding B; Ye M; Wang P; Bi Y; Wu S; Xu X; Guo Q; Wang M
    J Antimicrob Chemother; 2017 Jul; 72(7):1930-1936. PubMed ID: 28333323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation of
    Dulyayangkul P; Wan Nur Ismah WAK; Douglas EJA; Avison MB
    Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32312773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance to extended-spectrum beta-lactams by the emergence of SHV-12 and the loss of OmpK35 in Klebsiella pneumoniae and Escherichia coli in Malaysia.
    Palasubramaniam S; Muniandy S; Navaratnam P
    J Microbiol Immunol Infect; 2009 Apr; 42(2):129-33. PubMed ID: 19597644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional features of KPC-109, a novel 270-loop KPC-3 mutant mediating resistance to avibactam-based β-lactamase inhibitor combinations and cefiderocol.
    Di Pilato V; Codda G; Niccolai C; Willison E; Wong JLC; Coppo E; Frankel G; Marchese A; Rossolini GM
    Int J Antimicrob Agents; 2024 Jan; 63(1):107030. PubMed ID: 37931849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended-spectrum beta-lactamases and the permeability barrier.
    Martínez-Martínez L
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():82-9. PubMed ID: 18154531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.